Self-regulated therapeutic agent delivery system and method

Claim 2

A therapeutic agent delivery system comprising: a first housing defining a donor chamber and being adapted to retain at least one ionized therapeutic agent in the donor chamber; a second housing defining a receiving chamber and having an inlet and an outlet in fluid communication with the receiving chamber adapted to receive a physiologically tolerable liquid for flow communication from the inlet to the outlet; and a rate-controlling electret membrane in fluid contact with and separating the donor chamber from the receiving chamber, the membrane having a donor side and a receiving side.

Claim 3

The therapeutic agent delivery system of claim 1, wherein the membrane is made of a material having an electrokinetic potential that provides an ionic surface.

Claim 4

The therapeutic agent delivery system of claim 1 including delivery means for delivering the diffused therapeutic agent from the receiving chamber to a patient.

Claim 5

The therapeutic agent delivery system of claim 1, wherein the first housing further includes a vent in communication with the donor chamber, the vent including an air permeable hydrophobic sealing means.

Claim 6

The therapeutic agent delivery system of claim 2, wherein the rate-controlling electret membrane has its ionic surface modified such that therapeutic agent remains in the donor chamber until the electrostatic potential on the receiving side of the membrane is changed by the liquid flowing in contact with the membrane thereby driving at least a portion of the therapeutic agent in contact with the donor side of the membrane across the membrane from the donor chamber to the receiving chamber by electrostatic diffusion.

Claim 7

The therapeutic agent delivery system of claim 2, wherein the rate-controlling electret membrane is comprised of a polyelectrolyte salt and a porous, hydrophilic polymer matrix.

Claim 8

The therapeutic agent delivery system of claim 6, wherein the polyelectrolyte is sodium polystyrene sulfonate.

Claim 9

The therapeutic agent delivery system of claim 6, wherein the polymer matrix comprises a film having an ionic surface charge modified with amine functional groups and carboxyl functional groups.

Claim 10

The therapeutic agent delivery system of claim 8 wherein the polymer matrix is a modified Nylon film.

Claim 11

The therapeutic agent delivery system of claim 6, wherein the rate-controlling electret membrane has an ion exchange capacity averaging about 2.0 milliequivalents per dry gram weight.

Claim 12

The therapeutic agent delivery system of claim 1, wherein the electret membrane is captured between the first housing and the second housing by means of an interlocking ridge and groove around the periphery of the membrane.

Claim 13

The therapeutic agent delivery system of claim 1, wherein the donor chamber further includes an inlet port.

Claim 14

The therapeutic agent delivery system of claim 1 in disc-shaped form.

Claim 15

The therapeutic agent delivery system of claim 1, containing therapeutic agent in the donor chamber.

Claim 16

The therapeutic agent delivery system of claim 14, wherein the therapeutic agent is a drug.

Claim 17

The therapeutic agent delivery system of claim 1 composed of disposable, sterilizable physiologically tolerable material.

Claim 18

A therapeutic agent delivery system comprising: a first housing defining a donor chamber and having an inlet port and being adapted to retain at least one ionized therapeutic agent in the donor chamber; a second housing defining a receiving chamber and having an inlet and an outlet in fluid communication with the receiving chamber adapted to receive a physiologically tolerable liquid for flow communication from the inlet to the outlet; and a rate-controlling electret membrane in fluid contact with and separating the donor chamber from the receiving chamber, the membrane having a donor side and a receiving side, the electret membrane comprised of a polypeptide salt and a porous hydrophilic polymer matrix.

Claim 19

A therapeutic agent delivery system comprising: a first housing defining a donor chamber and having an inlet port and being adapted to retain at least one ionized therapeutic agent in the donor chamber; a second housing defining a receiving chamber and having an inlet and an outlet in fluid communication with the receiving chamber adapted to receive a physiologically tolerable liquid for flow communication from the inlet to the outlet; and a rate-controlling electret membrane in fluid contact with and separating the donor chamber from the receiving chamber, the membrane having a donor side and a receiving side, the electret membrane comprised of a polypeptide salt and a porous hydrophilic polymer matrix.

Claim 20

The therapeutic agent delivery system of claim 17, wherein the polymer matrix is a film having a charge modified ionic surface.

Claim 21

The therapeutic agent delivery system of claim 18, wherein the ionic surface comprises amine functional group sand carboxyl functional groups.

Claim 24

The device of claim 20 wherein the receiving chamber further includes a delivery means.

Claim 25

The device of claim 20 wherein the donor chamber further includes a vent in communication with the donor chamber.

Claim 26

The device of claim 20, wherein the rate-controlling membrane is comprised of a polyelectrolyte salt and a porous, hydrophilic polymer matrix.

Claim 29

In a method of administering therapeutic agent to a patient whereby a physiologically tolerable liquid is delivered to a patient by means of tubing attached to an infusion source containing the liquid, the improvement comprising including a self-regulated therapeutic agent delivery system between the patient and the infusion source, the therapeutic agent delivery system including: (a) a device defining a donor chamber and a receiving chamber separated by a rate-controlling membrane composed of a material having an electrokinetic potential to provide an ionic surface, the donor chamber being adapted to receive the therapeutic agent in ionized form and the receiving chamber being adapted to receive a physiologically tolerable liquid for flow communication through the receiving chamber to a delivery means, such that when a therapeutic agent is placed in the donor chamber and in contact with the membrane and received liquid flows in contact with the membrane through the receiving chamber the flow of the moving liquid changes the electrokinetic potential across the surface of the membrane and therapeutic agent in contact with the membrane electrostatically diffuses through the membrane in response thereto from the donor chamber to the receiving chamber whereby the rate of delivery of therapeutic agent from the system is self regulating, and (b) delivering the diffused therapeutic agent from the receiving chamber to the patient.

Claim 30

In a method of administering therapeutic agent to a patient whereby a physiologically tolerable liquid is delivered to a patient by means of tubing attached to an infusion source containing the liquid, the improvement comprising including a self-regulated therapeutic agent delivery system between the patient and the infusion source, the therapeutic agent delivery system including: (a) a device defining a donor chamber and a receiving chamber separated by a rate-controlling membrane composed of a material having an electrokinetic potential to provide an ionic surface, the donor chamber being adapted to receive the therapeutic agent in ionized form and the receiving chamber being adapted to receive a physiologically tolerable liquid for flow communication through the receiving chamber to a delivery means, such that when a therapeutic agent is placed in the donor chamber and in contact with the membrane and received liquid flows in contact with the membrane through the receiving chamber the flow of the moving liquid changes the electrokinetic potential across the surface of the membrane and therapeutic agent in contact with the membrane electrostatically diffuses through the membrane in response thereto from the donor chamber to the receiving chamber whereby the rate of delivery of therapeutic agent from the system is self regulating, and (b) delivering the diffused therapeutic agent from the receiving chamber to the patient.